During the past decade, STAT Research S.A. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "STAT Research S.A." are "Depressive Disorder, Major" (3 trials), "Obesity" (2 trials), "Overweight" (2 trials), "Anhedonia" (1 trials) and "Primary Biliary Cholangitis" (1 trials). Many other conditions were trialed in "STAT Research S.A." in a lesser frequency.

Most popular intervention types in "STAT Research S.A." are "Drug" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Aticaprant" (2 trials), "Tirzepatide" (2 trials), "Seladelpar 10 mg" (1 trials) and "Seladelpar 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "STAT Research S.A." are 6 trials for "All" genders.

Currently, there are NaN active trials in "STAT Research S.A.". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in STAT Research S.A., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in STAT Research S.A., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".